You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK

The Drug Safety Research Unit – an independent academic unit based in Southampton, UK – is planning to conduct an active surveillance study on COVID-19 vaccine following regulatory authorisation.